Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer (TASUKI-52)

NCT03117049 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: ONO-4538
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Bevacizumab
DRUG: Placebo

Sponsor

Ono Pharmaceutical Co., Ltd.

Collaborators

[object Object]